RHBC
R.H. Bluestein & Co’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,620
| Closed | -$283K | – | 321 |
|
|
2017
Q4 | $283K | Sell |
4,620
-2,710
| -37% | -$166K | 0.01% | 254 |
|
|
2017
Q3 | $467K | Buy |
+7,330
| New | +$467K | 0.03% | 168 |
|
|
2017
Q1 | – | Sell |
-413,877
| Closed | -$24.2M | – | 325 |
|
|
2016
Q4 | $24.2M | Sell |
413,877
-161,486
| -28% | -$9.44M | 1.58% | 32 |
|
|
2016
Q3 | $31M | Sell |
575,363
-325
| -0.1% | -$17.5K | 2.04% | 27 |
|
|
2016
Q2 | $42.3M | Buy |
575,688
+57,785
| +11% | +$4.25M | 3.24% | 9 |
|
|
2016
Q1 | $33.1M | Sell |
517,903
-50,597
| -9% | -$3.23M | 2.39% | 14 |
|
|
2015
Q4 | $39.1M | Buy |
568,500
+44,993
| +9% | +$3.1M | 2.44% | 14 |
|
|
2015
Q3 | $31M | Sell |
523,507
-27,093
| -5% | -$1.6M | 2.2% | 19 |
|
|
2015
Q2 | $36.6M | Buy |
550,600
+203,803
| +59% | +$13.6M | 2.22% | 17 |
|
|
2015
Q1 | $22.4M | Buy |
346,797
+18,033
| +5% | +$1.16M | 1.35% | 36 |
|
|
2014
Q4 | $19.4M | Sell |
328,764
-6,549
| -2% | -$387K | 1.21% | 36 |
|
|
2014
Q3 | $17.2M | Sell |
335,313
-3,818
| -1% | -$195K | 1.08% | 40 |
|
|
2014
Q2 | $16.5M | Sell |
339,131
-67,170
| -17% | -$3.26M | 0.98% | 43 |
|
|
2014
Q1 | $21.1M | Sell |
406,301
-11,164
| -3% | -$580K | 1.39% | 30 |
|
|
2013
Q4 | $22.2M | Sell |
417,465
-64,945
| -13% | -$3.45M | 1.4% | 27 |
|
|
2013
Q3 | $22.3M | Sell |
482,410
-120,456
| -20% | -$5.57M | 1.58% | 28 |
|
|
2013
Q2 | $26.9M | Buy |
+602,866
| New | +$26.9M | 2.37% | 12 |
|